Additionally, Yang and colleagues generated patient-derived xenograft (PDX) models from 107 patient samples of osteosarcoma, 84 (78.5%) of which had detectable FOLR1 mRNA expression, some to the level of FOLR1 mRNA expression by an ovarian carcinoma cell line. This evidence concerns the gene FOLR1 and ovarian carcinoma.